¾Ï ¿¬±¸¿Í Ä¡·á¿¡ °ü½ÉÀÌ ÀÖ´Â ±¹³» ¿Ü ¾ÏÀü¹®°¡µéÀÌ Âü¿©ÇÏ´Â Çмú´ëȸ ¹× ½ÉÆ÷Áö¿òÀ» ½ÃÇàÇÏ°í ÀÖÀ¸¸ç °øµ¿¿¬±¸ ¹× ±â¼ú °³¹ßÀ» ÃßÁøÇÏ°í ÀÖ½À´Ï´Ù. ¸Å³â ¾Ï¿¬±¸¼Ò Á¤±â ½ÉÆ÷Áö¿òÀ» °³ÃÖÇÏ¿© ±âÃÊ¿Í ÀÓ»óºÐ¾ßÀÇ Çй®Àû ±³·ù¿Í Çù·ÂÀ» ÅëÇÑ ¾ÏÀü¹®°¡µéÀÇ ±³·ùÀÇ ÀåÀ» ¿¾î¿À°í ÀÖ½À´Ï´Ù.
Á¦4Â÷ Á¤¹ÐÀÇ·á»ç¾÷´Ü ±¹Á¦½ÉÆ÷Áö¿ò °³ÃÖ
Á¦3Â÷ Á¤¹ÐÀÇ·á»ç¾÷´Ü ±¹Á¦½ÉÆ÷Áö¿ò °³ÃÖ
Á¦2Â÷ Á¤¹ÐÀÇ·á»ç¾÷´Ü ±¹Á¦½ÉÆ÷Áö¿ò °³ÃÖ
4´ë ¼ÒÀå¿¡ Á¾¾çÇ÷¾×³»°ú ¼ÀçÈ« ±³¼ö°¡ ÀÓ¸íµÊ
Á¦1Â÷ Á¤¹ÐÀÇ·á»ç¾÷´Ü ±¹Á¦½ÉÆ÷Áö¿ò °³ÃÖ
Á¦27ȸ °í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ½ÉÆ÷Áö¿ò °³ÃÖ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â ½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
Á¦26ȸ °í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò & ÀÓ»ó½ÃÇè ±Û·Î¹ú¼±µµ¼¾ÅÍ ½ÉÆ÷Áö¿ò °³ÃÖ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â ½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
Á¦25ȸ °í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ½ÉÆ÷Áö¿ò °³ÃÖ
Bridging the gap between cancer reserch and the clinic, ¹ß°£
Korea University Cancer Institute Symposium °³ÃÖ
The Convergence of New Technologies in Clinical Oncology, ¹ß°£
Korea University Cancer Institute Symposium °³ÃÖ
New Breakthroughs in cure for Melanoma, ¹ß°£
3´ë ¼ÒÀå¿¡ Á¾¾çÇ÷¾×³»°ú ±è¿È« ±³¼ö°¡ ÀÓ¸íµÊ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ½ÉÆ÷Áö¿ò(The Third Wave of Cancer Management) °³ÃÖ
The Third Wave of Cancer Management, ¹ß°£
21st Korea University Cancer Institute Symposium Cancer Stem Cell °³ÃÖ
Cancer Stem Cell, ¹ß°£
Multiplying benefits from Multidisciplinary treatment of Breast Cancer °³ÃÖ
Multiplying benefits from Multidisciplinary treatment of Breast Cancer, ¹ß°£
18th Korea Univercity Cancer Institute Symposium °³ÃÖ
Multidisciplinary treatment against gastrointestinal Cancer, ¹ß°£
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ½ÉÆ÷Áö¿ò
Harnessing Immune System for the treatment of Cancer, ¹ß°£
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ½ÉÆ÷Áö¿ò
Cancer Vaccine Strategy Recent Advances, ¹ß°£
Cancer Immunotherapy Current and Future Strategies °³ÃÖ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ½ÉÆ÷Áö¿ò °³ÃÖ
Cancer Immunotherapy : Current and Future Strategies, ¹ß°£
Á¦15ȸ °í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ½ÉÆ÷Áö¿ò
Signal Transduction and Cancer Research, ¹ß°£
Á¦14ȸ °í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò ½ÉÆ÷Áö¿ò
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â ½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
2´ë ¼ÒÀå¿¡ Á¾¾çÇ÷¾×³»°ú ±èÁؼ® ±³¼ö°¡ ÀÓ¸íµÊ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Çмú´ëȸ ¹× Æó¾Ï, À¯¹æ¾Ï/³¼Ò¾Ï À¯Àüü ¿¬±¸¼¾ÅÍ ½ÉÆ÷Áö¿ò
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â ½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Çмú´ëȸ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â ½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Çмú´ëȸ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â ½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
Á¾¾çÀÇ Ä§½À°ú ÁøÇà, ¹ß°£
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Çмú´ëȸ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â ½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
¼¿ï½Ã º¸°Ç°£È£»ç Àü¹®±³À°°úÁ¤
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Çмú´ëȸ
¾Ï°ú ¿°»öü ÀÌ»ó, ¹ß°£
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Çмú´ëȸ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
1´ë ¼ÒÀå¿¡ ¹æ»ç¼±Á¾¾çÇаú ÃÖ¸í¼± ±³¼ö°¡ ÀÓ¸íµÊ
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¾¾ç¿¬±¸È¸ Çмú´ëȸ
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¤±â½ÉÆ÷Áö¿ò °ÀÇ·Ï, ¹ß°£
°í·Á´ëÇб³ ¾Ï¿¬±¸¼Ò Á¾¾ç½ÉÆ÷Áö¿ò °³ÃÖ